Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Apoptosis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Cell Death Medicine & Life Sciences
DNA Damage Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2017

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors

Izumchenko, E. , Paz, K. , Ciznadija, D. , Sloma, I. , Katz, A. , Vasquez-Dunddel, D. , Ben-Zvi, I. , Stebbing, J. , McGuire, W. , Harris, W. , Maki, R. , Gaya, A. , Bedi, A. , Zacharoulis, S. , Ravi, R. , Wexler, L. H. , Hoque, M. O. , Rodriguez-Galindo, C. , Pass, H. , Peled, N. & 4 others Davies, A., Morris, R., Hidalgo, M. & Sidransky, D. 2017 In : Annals of Oncology. 28, 10, p. 2595-2605 11 p.

Research output: Research - peer-reviewArticle

Heterografts
Neoplasms
Therapeutics
Exome
Pharmaceutical Preparations

SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells

Ozawa, H., Ranaweera, R. S., Izumchenko, E., Makarev, E., Zhavoronkov, A., Fertig, E. J., Howard, J. D., Markovic, A., Bedi, A., Ravi, R., Perez, J., Le, Q. T., Kong, C. S., Jordan, R. C., Wang, H., Kang, H., Quon, H., Sidransky, D. & Chung, C. H. Sep 1 2017 In : Clinical Cancer Research. 23, 17, p. 5162-5175 14 p.

Research output: Research - peer-reviewArticle

Head and Neck Neoplasms
Cetuximab
Carcinoma, squamous cell of head and neck
Phenotype
Cell Line

Patient-derived xenografts as tools in pharmaceutical development

Izumchenko, E., Meir, J., Bedi, A., Wysocki, P. T., Hoque, M. O. & Sidransky, D. 2016 (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Research - peer-reviewArticle

Heterografts
Pharmaceutical Preparations
Neoplasms
Therapeutics
Decision Making

A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma

Gilbert, J., Schell, M. J., Zhao, X., Murphy, B., Tanvetyanon, T., Leon, M. E., Hayes, D. N., Haigentz, M., Saba, N., Nieva, J., Bishop, J., Sidransky, D., Ravi, R., Bedi, A. & Chung, C. H. 2015 In : Oral Oncology. 51, 4, p. 376-382 7 p.

Research output: Research - peer-reviewArticle

sorafenib
Cetuximab
Carcinoma, squamous cell of head and neck
Disease-Free Survival
Neoplasms

Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA

Izumchenko, E., Chang, X., Brait, M., Fertig, E., Kagohara, L. T., Bedi, A., Marchionni, L., Agrawal, N., Ravi, R., Jones, S., Hoque, M. O., Westra, W. H. & Sidransky, D. Sep 16 2015 In : Nature Communications. 6, 8258

Research output: Research - peer-reviewArticle

neoplasms
sequencing
progressions
lungs
deoxyribonucleic acid